PubMed:32290293 / 1559-1841 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T28","span":{"begin":90,"end":95},"obj":"NCBITaxon:10239"},{"id":"T29","span":{"begin":90,"end":95},"obj":"GO:0006260"},{"id":"T30","span":{"begin":96,"end":107},"obj":"GO:0006260"},{"id":"T31","span":{"begin":181,"end":197},"obj":"GO:0045087"},{"id":"T32","span":{"begin":198,"end":204},"obj":"UBERON:0002405"},{"id":"T33","span":{"begin":198,"end":214},"obj":"GO:0006955"},{"id":"T34","span":{"begin":246,"end":258},"obj":"GO:0065007"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"These agents can be divided into two broad categories, those that can directly target the virus replication cycle, and those based on immunotherapy approaches either aimed to boost innate antiviral immune responses or alleviate damage induced by dysregulated inflammatory responses."}

{"project":"Inflammaging","denotations":[{"id":"T9","span":{"begin":0,"end":282},"obj":"Sentence"},{"id":"T9","span":{"begin":0,"end":282},"obj":"Sentence"}],"text":"These agents can be divided into two broad categories, those that can directly target the virus replication cycle, and those based on immunotherapy approaches either aimed to boost innate antiviral immune responses or alleviate damage induced by dysregulated inflammatory responses."}